This announcement is a separate document:
方盛制药关于董事会对2023年度独立董事独立性自查情况的专项报告
Fangsheng Pharmaceutical's special report on the board of directors's self-inspection of the independence of independent directors in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.